06.15.2015
Improve Outcomes
$775,061.00
15 months
Feasibility Study of an Insulin-only Bionic Pancreas
Funding to determine the whether an insulin only automated glucose control system (Bionic Pancreas) provides safe and effective glycemic control with a fixed target glucose level (set-point) and a dynamic system that adapts glucose levels for people with type 1 diabetes.